Vivek Radhakrishnan
Impact in
-
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Hemoglobinopathies and Related Disorders
- Chronic Lymphocytic Leukemia Research
Papers in
- Oncology 21
- CAR-T cell therapy research 9
- Hematology 17
- Hematopoietic Stem Cell Transplantation 6
- Acute Myeloid Leukemia Research 4
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Reena Nair (18 shared papers)Deepak Kumar Mishra (14 shared papers)Sanjay Bhattacharya (6 shared papers)Mammen Chandy (15 shared papers)Jeevan Kumar (14 shared papers)Mammen Chandy (13 shared papers)Mayur Parihar (12 shared papers)Andrew Davies (2 shared papers)
- Journals
- Blood (4 papers)Journal of Clinical Oncology (2 papers)Frontiers in Oncology (2 papers)Cytometry Part B Clinical Cytometry (1 paper)Hematological Oncology (1 paper)
- Partner nations
- IndiaUnited StatesUnited Kingdom
In The Last Decade
Vivek Radhakrishnan
41 papers receiving 204 citations
Peers
Comparison fields: 5 of 52
- Hematology 54
- Genetics 43
- Oncology 63
- Public Health, Environmental and Occupational Health 55
- Pathology and Forensic Medicine 31
Countries citing papers authored by Vivek Radhakrishnan
This map shows the geographic impact of Vivek Radhakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Radhakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Radhakrishnan more than expected).
Fields of papers citing papers by Vivek Radhakrishnan
This network shows the impact of papers produced by Vivek Radhakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Radhakrishnan. The network helps show where Vivek Radhakrishnan may publish in the future.
Co-authors
The 25 scholars most cited alongside Vivek Radhakrishnan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 27 | |
| 2 | 2019 | 20 | |
| 3 | 2020 | 19 | |
| 4 | 2019 | 17 | |
| 5 | 2020 | 10 | |
| 6 | 2024 | 9 | |
| 7 | 2020 | 9 | |
| 8 | 2021 | 7 | |
| 9 | 2018 | 7 | |
| 10 | 2018 | 7 | |
| 11 | 2021 | 6 | |
| 12 | 2022 | 6 | |
| 13 | 2021 | 6 | |
| 14 | 2020 | 5 | |
| 15 | 2010 | 5 | |
| 16 | 2020 | 4 | |
| 17 | 2020 | 4 | |
| 18 | 2021 | 4 | |
| 19 | 2022 | 3 | |
| 20 | 2022 | 3 |
About Vivek Radhakrishnan
Vivek Radhakrishnan is a scholar working on Oncology, Hematology, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Genetics, having authored 47 papers that have together received 216 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (13 papers), CAR-T cell therapy research (9 papers), Acute Lymphoblastic Leukemia research (8 papers), Hematopoietic Stem Cell Transplantation (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Mycobacterium research and diagnosis (3 papers). The work is most often cited by research in Hematology (54 citations), Genetics (43 citations), Oncology (63 citations), Public Health, Environmental and Occupational Health (55 citations) and Pathology and Forensic Medicine (31 citations). Vivek Radhakrishnan has collaborated with scholars based in India, United States and United Kingdom. Frequent co-authors include Reena Nair, Deepak Kumar Mishra, Sanjay Bhattacharya, Mammen Chandy, Jeevan Kumar, Mammen Chandy, Mayur Parihar, Andrew Davies, Arijit Nag and Neeraj Arora. Their work appears in journals such as Blood, Journal of Clinical Oncology, Frontiers in Oncology, Cytometry Part B Clinical Cytometry and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.